Fate Therapeutics Inc (FATE)

Fate Therapeutics Inc (FATE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $231M; returns 1 day +1.0%, 1 week +17.9%, 1 year +38.8%.

Fate Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class, 'off-the-shelf' cellular immunotherapies for cancer and autoimmune diseases.

Groups FATE belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Immunotherapy
• Regenerative Medicine
• Healthcare
• Life Sciences
• Autoimmune Diseases
• Oncology
• Cancer Therapeutics
• Clinical Stage

FATE financial model: income statement, cash flow and balance sheet